logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

HR+ metastatic breast cancer: CTC count successfully guides first-line therapy

CTC count-driven therapy is found to be noninferior to clinician choice-guided first-line therapy.